δ in Dementia Clinical Trials

Abroad (travel likely)Recruiting

Conditions

Alzheimer's Disease (AD) · Dementia · Cognitive Decline · Mild Cognitivie Impairment (MCI)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Univeristy of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas, United States
Contact: Study coordinator (Samuel Guess) · guesss@uthscsa.edu · 210 567 8133
Contact: Study coordinator (Floyd Jones) · JONESFA@uthscsa.edu · JONESFA@uthscsa.edu

Study leads

Donald R. Royall, MD
Principal Investigator
University of Texas

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Low-Dose Radiotherapy for Alzheimer's Disease

Alzheimer Dementia · Dementia · Alzheimer Dementia (AD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Winter Park, United States

Social-cognitive Functioning: Validation of a New Neuropsychological Test

Alzheimer's Disease (AD) · Lewy Body Dementia (LBD) · Frontotemporal Degeneration (FTD)

Abroad (travel likely)Recruiting

Paris, France

Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

Abroad (travel likely)RecruitingPHASE3

Wuhan, China · Shanghai, China

A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease

AD · Early Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Chongqing, China